Clinical Trial Update: An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

View source ↗

Summary

An observational study conducted by AstraZeneca in Russia examines molecular profiling of advanced and aggressive endometrial cancer and first-line treatment ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Endometrial Cancer | Status: RECRUITING